[1]
Odierna, G.L. and Phillips, W. 2023. Targeting the safety factor for neuromuscular transmission to treat myasthenia gravis: Safety factor for neuromuscular transmission. RRNMF Neuromuscular Journal. 4, 3 (Aug. 2023). DOI:https://doi.org/10.17161/rrnmf.v4i3.19543.